Dengue Preventive Strategies: Third World (My World) Entrepreneurs Wake Up and Please Stand Up

Abstract

It has taken me almost 19 years and observing/enduring/ignoring 20 seasons of dengue fever in our country’s capital, Delhi to finally say “Enough is enough”. How many more precious lives dengue will consume before infrastructure resolves to fight back and eradicate dengue. Why the development of vaccine has been difficult for this mosquito borne disease. The good news is that the WHO has promising data accumulation in favor of live attenuated recombinant tetravalent dengue vaccine titled CYD-TDV that has taken up the arduous challenge to counter all four serotypes of dengue virus. Hopefully, by April 2016, the WHO may have their recommendations (if any) about how and when to use CYD-TDV. Subsequently, the ball will be in the court of dengue-endemic nations’ regulatory authorities to take on the implementations of the WHO recommendations. Herein will lay the prerogative of dengue-endemic nations’ physician-entrepreneurs/pharmaceutical-entrepreneurs in the Third World (my world) to take it upon them to ensure that although they have been slow to catch up (already 20 seasons have flown past), they should not miss the train now once the WHO publishes its recommendations in near future so that hopefully, the next season sees the dawn of hope and shifting of gears from economy-draining sluggish anti-dengue campaign to economy-driving future eradicate-dengue campaign initiating from the dengue-endemic nations across the world, including India.